A RETROSPECTIVE STUDY TO ASSESS THE CLINICAL OUTCOME, BIOLOGICAL PATTERN AND TREATMENT OPTIONS IN PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA - A SHORT TERM ANALYSIS IN ONE CENTER

被引：0
|
作者：
Vladareanu, A. M. [1 ]
Bumbea, H. [1 ]
Nicolescu, A. [1 ]
Onisai, M. [1 ]
Cisleanu, D. [1 ]
Voican, I. [1 ]
Radesi, S. [1 ]
Ciufu, C. [1 ]
Vasilache, V. [1 ]
Marinescu, C. [1 ]
Begu, M. [1 ]
Dervesteanu, M. [1 ]
Jercan, O. [1 ]
Dobrea, C. [2 ]
Neagu, S. [1 ]
Savlovschi, C. [1 ]
Stamatoiu, A. [1 ]
Pantu, H. [1 ]
机构：
[1] Emergency Univ Hosp Bucharest, Bucharest, Romania
[2] Victor Babes Natl Inst Dev & Res, Bucharest, Romania
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1123
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [31] Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study
    Damien Contou
    Romain Sonneville
    Florence Canoui-Poitrine
    Gwenhaël Colin
    Rémi Coudroy
    Frédéric Pène
    Jean-Marc Tadié
    Martin Cour
    Gaëtan Béduneau
    Antoine Marchalot
    Laurent Guérin
    Sébastien Jochmans
    Stephan Ehrmann
    Nicolas Terzi
    Sébastien Préau
    François Barbier
    Guillaume Schnell
    Damien Roux
    Olivier Leroy
    Claire Pichereau
    Elodie Gélisse
    Lara Zafrani
    Richard Layese
    Christian Brun-Buisson
    Armand Mekontso Dessap
    Nicolas de Prost
    Intensive Care Medicine, 2018, 44 : 1502 - 1511
  • [32] Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study
    Muntanola, Ana
    Teresa Villalobos, Maria
    Gonzalez-Villambrosia, Sonia
    Rodriguez-Salazar, Maria Jose
    Jimenez-Ubieto, Ana
    Bastidas-Mora, Gabriela
    Cordoba, Raul
    Infante, Maria
    Jesus Vidal, Maria
    Javier Diaz, Francisco
    Baile, Monica
    Bastos-Oreiro, Mariana
    Panizo, Carlos
    Manuel Sancho, Juan
    Navarro, Belen
    Garcia, Tomas
    Escoda, Lourdes
    Abrisqueta, Pau
    Terol, Maria Jose
    de Campo, Raquel
    Mozas, Pablo
    Lopez-Guillermo, Armando
    Salar, Antonio
    Montalban, Carlos
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (04) : 776 - 784
  • [33] SHORT- AND LONG-TERM OUTCOME OF PATIENTS TREATED WITH INDIGO NATURALIS FOR INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER RETROSPECTIVE STUDY
    Matsuno, Yuichi
    Hirano, Atsushi
    Okamoto, Yasuharu
    Fuyuno, Yuta
    Fujioka, Shin
    Umeno, Junji
    Moriyama, Tomohiko
    Torisu, Takehiro
    Kitazono, Takanari
    Esaki, Motohiro
    GASTROENTEROLOGY, 2019, 156 (03) : S34 - S35
  • [34] SHORT- AND LONG-TERM OUTCOME OF PATIENTS TREATED WITH INDIGO NATURALIS FOR INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER RETROSPECTIVE STUDY
    Matsuno, Yuichi
    Hirano, Atsushi
    Okamoto, Yasuharu
    Fuyuno, Yuta
    Fujioka, Shin
    Umeno, Junji
    Moriyama, Tomohiko
    Torisu, Takehiro
    Kitazono, Takanari
    Esaki, Motohiro
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S24 - S24
  • [35] Comprehensive analysis of clinicalf eatures, treatment options, overall survival, and prognostic factors in lymphoma cell leukemia patients: A retrospective study
    Kang, Ya
    Fang, Kun
    Wang, Mengchang
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (07) : 1961 - +
  • [36] Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study
    Acar, Ramazan
    Paydas, Semra
    Yildirim, Murat
    Kilicarslan, Emrah
    Sahin, Ugur
    Dogan, Ali
    Guven, Deniz C.
    Ekinci, Omer
    Tiglioglu, Mesut
    Erdogan, Isil
    Elibol, Tayfun
    Kiziloz, Halil
    Aykan, Musa B.
    Sayin, Selim
    Kaptan, Kursat
    Soydan, Ender
    Gokmen, Ayla
    Esen, Ramazan
    Barista, Ibrahim
    Albayrak, Murat
    Erturk, Ismail
    Yildiz, Birol
    Keskin, Gulsema Y.
    Ayli, Meltem
    Karadurmus, Nuri
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S138 - S144
  • [37] SHORT TERM OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY (ESG) IN TYPE III OBESE PATIENTS: A CLINICAL, RETROSPECTIVE, SINGLE CENTER STUDY
    Pontecorvi, Valerio
    Laterza, Lucrezia
    Bove, Vincenzo
    Carlino, Giorgio
    Gallo, Camilla
    Orlandini, Beatrice
    Papparella, Luigi Giovanni
    De Siena, Martina
    Matteo, Maria Valeria
    Boskoski, Ivo
    Costamagna, Guido
    GASTROINTESTINAL ENDOSCOPY, 2021, 93 (06) : AB8 - AB9
  • [38] Non-pegylated lyposomal doxorubicin, cyclophosphamide, vincristine, prednisone and rituximab (R-COMP) as initial treatment for patients with splenic marginal zone lymphoma (SMZL). A GISL study
    Iannitto, Emilio
    Luminari, Stefano
    Mammi, Caterina
    Minardi, Viviana
    Merli, Francesco
    Angrilli, Francesco
    Stelitano, Caterina
    Cesaretti, Marina
    Franco, Giovanni
    Carella, Angelo M.
    Federico, Massimo
    BLOOD, 2007, 110 (11) : 389A - 389A
  • [39] Non-pegylated lyposomal doxorubicin, cyclophosphamide,vincristine, prednisone and rituximab (R-COMP) as initial treatment for patients with splenic marginal zone lymphoma (SMZL): A GISL study
    Iannitto, E.
    Luminari, S.
    Mammi, C.
    Minardi, V
    Merli, F.
    Angrilli, F.
    Stelitano, C.
    Cesaretti, M.
    Franco, G.
    Carella, A. M.
    Federico, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 185 - 185
  • [40] Non-pegylated lyposomal doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab (R-COMP) as initial treatment for patients with splenic marginal zone lymphoma (SMZL): A GISL study
    Iannitto, E.
    Luminari, S.
    Mammi, C.
    Minardi, V.
    Merli, F.
    Angrilli, F.
    Stelitano, C.
    Cesaretti, M.
    Franco, G.
    Carella, A. M.
    Federico, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345